Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Nutr. 2007 Aug;26(4):409-15. Epub 2007 Apr 20.

Update on non-alcoholic fatty liver disease in children.

Author information

  • 12nd Department of Pediatrics, Aristotle University of Thessaloniki, School of Medicine, St Kiriakidi 1 Thessalonki, Greece. vellada@otenet.gr

Abstract

Non-alcoholic fatty liver disease (NAFLD) is probably the most common cause of liver disease in the pediatric community. It is closely associated with obesity and insulin resistance. NAFLD may lead to non-alcoholic steatohepatitis (NASH). Although NASH is a prerequisite for the definition of NAFLD in adults and children, distinct differences are often apparent in the extent or location of fat, inflammation and fibrosis. Confirmation of the diagnosis of NAFLD can usually be achieved by imaging studies; however, staging the disease requires a liver biopsy. Current treatment relies on weight loss and exercise, although various insulin-sensitizing agents, antioxidants and medications appear promising. The aim of this review is to summarize what is known about pediatric NAFLD in terms of prevalence, pathogenesis, diagnosis, histology and treatment.

PMID:
17449148
DOI:
10.1016/j.clnu.2007.02.002
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center